Gary Titus Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Gary Titus.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Gary Titus. Gary Titus is V.P. and Chief Acctg Officer in ARCA biopharma, Inc. ($ABIO) and VP Finance, Chief Acct.Officer in ARCA biopharma, Inc. ($ABIO) and Chairman and Secretary in ImmunoCellular Therapeutics, Ltd. ($IMUC) and Director in ImmunoCellular Therapeutics, Ltd. ($IMUC).
Latest Insider Trading Transactions of Gary Titus
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 21 2016 | IMUC | ImmunoCellular The ... | Titus Gary | Chairman and Secret ... | Option Exercise | A | 0.24 | 156,750 | 37,620 | 156,750 | |
| Sep 22 2015 | IMUC | ImmunoCellular The ... | Titus Gary | Director | Option Exercise | A | 0.00 | 10,000 | 0 | 10,000 | |
| Sep 22 2015 | IMUC | ImmunoCellular The ... | Titus Gary | Director | Grant | A | 0.00 | 10,000 | 0 | 28,000 | 18 K to 28 K (+55.56 %) |
| Jun 30 2015 | IMUC | ImmunoCellular The ... | Titus Gary | Director | Option Exercise | A | 0.48 | 75,000 | 36,000 | 75,000 | |
| Aug 03 2005 | ABIO | ARCA biopharma, In ... | Titus Gary | VP Finance, Chief A ... | Option Exercise | A | 9.16 | 190 | 1,740 | 190 | |
| Aug 03 2005 | ABIO | ARCA biopharma, In ... | Titus Gary | VP Finance, Chief A ... | Option Exercise | A | 9.16 | 124,810 | 1,143,260 | 124,810 | |
| Aug 03 2005 | ABIO | ARCA biopharma, In ... | Titus Gary | VP Finance, Chief A ... | Buy | I | 6.30 | 167 | 1,052 | 167 | 0 to 167 |
| Aug 03 2005 | ABIO | ARCA biopharma, In ... | Titus Gary | VP Finance, Chief A ... | Buy | I | 6.60 | 159 | 1,049 | 159 | 0 to 159 |
| Feb 24 2005 | ABIO | ARCA biopharma, In ... | Titus Gary | VP Finance, Chief A ... | Buy | P | 7.51 | 1,500 | 11,265 | 1,879 | 379 to 1.9 K (+395.78 %) |
| Feb 24 2005 | ABIO | ARCA biopharma, In ... | Titus Gary | VP Finance, Chief A ... | Buy | I | 7.69 | 136 | 1,046 | 379 | 243 to 379 (+55.97 %) |
| Jan 11 2005 | ABIO | ARCA biopharma, In ... | Titus Gary | VP Finance, Chief A ... | Option Exercise | A | 9.83 | 10,833 | 106,488 | 10,833 | |
| Jan 11 2005 | ABIO | ARCA biopharma, In ... | Titus Gary | VP Finance, Chief A ... | Option Exercise | A | 9.83 | 39,167 | 385,012 | 39,167 | |
| Sep 15 2004 | ABIO | ARCA biopharma, In ... | Titus Gary | V.P. and Chief Acct ... | Option Exercise | A | 9.67 | 19,932 | 192,742 | 19,932 | |
| Sep 15 2004 | ABIO | ARCA biopharma, In ... | Titus Gary | V.P. and Chief Acct ... | Option Exercise | A | 9.67 | 20,068 | 194,058 | 20,068 |
Page: 1